Hexagon Nutrition IPO

Listed Mainboard
Min Investment
₹14,985
333 Shares
Min Investment
₹14,985 · 333 Shares
Open Jun 05
Close Jun 09
Allotment Jun 10
Refund Jun 11
Listing Jun 12
Price Band ₹42–45
Lot Size 333 shares
Issue Size ₹139 Cr
Listed At ₹48.25 +7.2%
Subscribed 53.48×
Listed On BSE & NSE
Listing Price
₹48.25 (+7.22%)
vs issue price
Check allotment status →
Current Price (BSE)
₹68.75 (+52.78%)
as of 08 Oct, 3:29 pm IST

Market Sentiment

Grey Market Premium What is GMP?
+₹6
+13.3%
Est. Listing: ₹51
Updated: Jun 11, 2026 7:07 pm
GMP estimate ₹51
Actual listing ₹48.25
Listed below the GMP estimate by ₹2.75 (-5.4%)
Subscription Status
QIB
19.77x
NII
161.21x
bNII (>10L)
183.16x
sNII (2-10L)
117.31x
Retail
26.57x
Total
53.48x
Updated: Jun 09, 2026 4:58 pm IST
Analysis Score 75 / 100
Data: 80%
GMP Score 60
Subscription Score 100
Financial Health 60
Score updates live as GMP/subscription change. For information only — not investment advice.

IPO Details

Price Band₹42–45 per equity share
Face Value₹1 Per Equity Share
Lot Size 333 shares (Min ₹14,985)
Total Issue Size ₹138.87 crore
Issue TypeBook Built Issue
Lead Manager Cumulative Capital Pvt. Ltd. , Catalyst Capital Partners Pvt. Ltd.
Registrar Kfin Technologies Ltd.
Listing atBSE & NSE
BSE Code544785
Listing Price₹48.25
Listing Gain+7.22%

Day-wise Subscription (times subscribed)

Category Day 1 Day 4 Day 5
QIB 0.00x 0.17x 19.77x
NII 2.03x 6.70x 161.21x
bNII > ₹10L 1.32x 5.04x 183.16x
sNII 2-10L 3.45x 10.03x 117.31x
Retail 2.43x 6.22x 26.57x
Total 1.65x 4.59x 53.48x

Market Lot Size

Category Lots Shares Amount (₹)
Retail Minimum 1 333 ₹14,985
Budget to Lots Calculator ▼
₹

IPO Reservation

Category Shares Offered Shares %
QIB61,72,15620.00%
NII (HNI)46,28,95615.00%
bNII > ₹10L30,85,97110.00%
sNII < ₹10L15,42,9855.00%
Retail1,08,00,89635.00%
Anchor92,57,69630.00%
Total3,08,59,704

Financial Analysis

Financial Data

ROE
12.46%
ROCE
17.06%
Debt/Equity
0.14
NAV/Share
₹15.91
Revenue Growth
8.76%
Profit Margin
7.36%

Financial Performance

Metric 2023 2024 2025 Dec 2025
Revenue 281.65 304.62 331.29 275.57
Expense 267.02 285.48 296.78 239.83
Profit (PAT) 5.82 12.21 24.38 27.03
Total Assets 288.90 250.54 261.36 327.60
Values in Crores (₹)

Peer Comparison

Company EPS P/E
Zydus Wellness Limited 10.90 46.22
Nestlé India Limited 16.63 88.86

Promoters & Holding Pattern

Promoters: Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar and Nikhil Arun Kelkar

Shareholding No. of Shares Holding %
Promoter Holding Pre Issue 12,29,18,109 89.41%
Promoter Holding Post Issue 12,29,18,109 64.29%

Strengths & Risks

Strengths
  • Heavily oversubscribed — 53.5x overall (so far).
  • Strong institutional (QIB) demand — 19.8x.
  • Low leverage — debt/equity of 0.14.
Risks & Concerns

Our data checks haven't flagged a specific concern for Hexagon Nutrition — but that isn't a clean bill of health. Read the risk-factors section of the RHP, which lists company-specific risks our data can't capture.

Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.

Company Information

About Hexagon Nutrition

Hexagon Nutrition Limited, founded in 1993, is one of the leading nutrition companies in India. The firm focuses on developing and manufacturing across 3 verticals: Micronutrient Premix Products, Clinical Nutrition, and Therapeutic Foods. The company runs its 3 manufacturing facilities in India, located at Nasik, Chennai, and Thoothukudi, as well as an international facility in Tashkent, Uzbekistan. Its product portfolio is divided into 3 segments: Hexagon Nutrition sells its products across multiple channels, such as Retail medical stores/pharmacies, Hospitals, E-Commerce websites, Online Medicine Platforms, and through its own websites like Pentasure, Obesigo, Pediagold, and Nutrone. The company has 342 distributors in India and has exported to more than 75 countries in Asia, Africa, Europe, and South America.

Company Contact Information

Hexagon Nutrition Ltd., 404 Global Chamber, Adarsh Nagar Link Road, Andheri (W), Mumbai, Maharashtra, 400053

Resources & Documents

Anchor Investors

Anchor Bidding Date
June 04, 2026
Shares Offered to Anchors
92,57,696
Lock-in End (30 Days, 50%)
July 10, 2026
Lock-in End (90 Days, 50%)
September 08, 2026

Hexagon Nutrition IPO - Quick Take

Hexagon Nutrition has set a price band of Rs 42–Rs 45 per share for an issue size of Rs 139 crore. The stock listed with a 7.22% gain versus its issue price on June 12, 2026.

Hexagon Nutrition Limited, founded in 1993, is one of the leading nutrition companies in India. The firm focuses on developing and manufacturing across 3 verticals: Micronutrient Premix Products, Clinical Nutrition, and Therapeutic Foods.

The issue is promoted by Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar and Nikhil Arun Kelkar with Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Pvt. Ltd. acting as lead manager.

On fundamentals, the company is posting revenue growth of 8.8%, a profit margin of 7.4%, return on equity of 12.5% in its most recent reported period. Listed peers in this segment include Zydus Wellness Limited (P/E 46.22x) and Nestlé India Limited (P/E 88.86x) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.

On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.

Frequently Asked Questions

The price band of Hexagon Nutrition IPO is Rs 42 to Rs 45 per share. Face value is Rs 1 per share.

The total issue size of Hexagon Nutrition IPO is Rs 139 crore.

Retail investors must apply for a minimum of 1 lot of 333 shares, requiring an investment of Rs 14,985. Maximum retail application is 13 lots (4329 shares, approx Rs 1,94,805).

Hexagon Nutrition IPO opens for subscription on June 05, 2026 and closes on June 09, 2026. Anchor investor bidding is scheduled for June 04, 2026.

The expected allotment date for Hexagon Nutrition IPO is June 10, 2026. Refunds for unsuccessful applicants are expected on June 11, 2026.

Hexagon Nutrition IPO is scheduled to list on June 12, 2026 on both BSE and NSE. BSE script code: 544785, NSE symbol: –, ISIN: –.

The current GMP (Grey Market Premium) of Hexagon Nutrition IPO is +Rs 6 (+13.3% over issue price). GMP is an unofficial grey market indicator and may change through the subscription window. See the GMP chart on this page for the full trend.

Hexagon Nutrition IPO is currently subscribed 53.48 times overall — retail at 26.57x, QIB at 19.77x, NII at 161.21x. Live subscription data updates multiple times per day on open-issue days.

Based on the current retail subscription of 26.57x for Hexagon Nutrition IPO, the estimated retail allotment probability is approximately 4.3%. This is a low probability — approximately 4 out of every 100 retail applications may receive allotment.

The registrar for Hexagon Nutrition IPO is Kfin Technologies Ltd.. After the allotment date, you can check your allotment status on the registrar's official website by entering your PAN, application number, or demat account details. Allotment status is also available on the BSE and NSE websites.

The book running lead manager(s) for Hexagon Nutrition IPO are Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Pvt. Ltd..

The promoter(s) of Hexagon Nutrition are Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar and Nikhil Arun Kelkar.

Hexagon Nutrition IPO GMP — What It Means

GMP stops mattering once the shares trade — it only ever estimated the listing price. The summary at the top of this page compares the last pre-listing GMP with how the shares actually listed.

See the full Hexagon Nutrition GMP history and trend, or learn how grey market premium works and how reliable it is.

0 Comments

No comments yet. Be the first to share your opinion!

GMP Update